Skip to main content
Blenrep 50 mg/mL injection, powder, for solution by GlaxoSmithKline LLC
Blenrep, 50 mg/mL, injection, powder, for solution Available on prescription only. Listed by GlaxoSmithKline LLC.
Prescription only

Blenrep

belantamab mafodotin

Listed by GlaxoSmithKline LLC

Strength
50 mg/mL
Form
Injection, Powder, For Solution
Route
Intravenous

What it contains

  • Belantamab Mafodotin 50 mg/mL

FDA record

Dosage form Injection, Powder, For Solution
Route Intravenous
Approval route BLA — biologic licence
NDC code 0173-0913
FDA application BLA761440
RxNorm concept 2725585
Package sizes listed 1
Marketed since October 2025

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.